APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 78 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $136,000 | +123.0% | 18,600 | +12.7% | 0.01% | +200.0% |
| Q2 2018 | $61,000 | -4.7% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $64,000 | +60.0% | 16,500 | +47.3% | 0.00% | +100.0% |
| Q4 2017 | $40,000 | -40.3% | 11,200 | -34.4% | 0.00% | -50.0% |
| Q3 2017 | $67,000 | -60.4% | 17,081 | -48.4% | 0.00% | -71.4% |
| Q2 2017 | $169,000 | -25.9% | 33,100 | 0.0% | 0.01% | -41.7% |
| Q1 2017 | $228,000 | +6.5% | 33,100 | +44.5% | 0.01% | -14.3% |
| Q4 2016 | $214,000 | +20.2% | 22,900 | +25.8% | 0.01% | +40.0% |
| Q3 2016 | $178,000 | – | 18,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |